- Home
- Equipment
- north america
- chronic inflammatory disease
Refine by
Chronic Inflammatory Disease Equipment Supplied In North America
12 equipment items found
Manufactured by:Valeo Pharma Inc. based inKirkland, QUEBEC (CANADA)
Asthma is a chronic inflammatory disease that causes the airways in the lungs to narrow and swell. Symptoms include wheezing, breathlessness, chest tightness, cough and asthma attacks ...
Manufactured by:Setpoint Medical Corporation based inValencia, CALIFORNIA (USA)
SetPoint Medical created a therapy to offer patients and providers a better alternative for the treatment of chronic inflammatory diseases with potentially less risk and lower cost than drug therapy. SetPoint Medical’s bioelectronic system is free of routine injections or pills and may eliminate the risks and substantial cost associated ...
Manufactured by:SFA Therapeutics, Inc. based inJenkintown, PENNSYLVANIA (USA)
SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Fulvic Acid can modulate the immune system, influence the oxidative state of cells, and improve gastrointestinal function. Fulvic Acid has the potential for researching chronic inflammatory diseases, including ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Infliximab prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy ...
Manufactured by:Quansys Biosciences Inc. based inLogan, UTAH (USA)
In the healthy immune system, CXCL-1 is produced by monocytes, epithelial cells, and fibroblasts in response to inflammatory activity. It induces neutrophil migration thought chemotaxis and has antimicrobial effects. It is also capable of promoting lymphatic tube and blood vessel formation within the circulatory system. In individuals with chronic ...
Manufactured by:Botanix Pharmaceuticals based inNorth Perth, AUSTRALIA
BTX1702 is a new product opportunity for the treatment of papulopustular rosacea. Rosacea is a chronic inflammatory skin disease that often begins with a tendency to blush or flush more easily than other people, but can progress into many subtypes, including papulopustular rosacea. Papulopustular rosacea is a highly visible and ...
Manufactured by:Benevolent based inLondon, UNITED KINGDOM
Advancing a potent and selective Atopic Dermatitis treatment through the clinic. What is Atopic Dermatitis? Atopic Dermatitis (AD), the most common type of eczema, is a chronic relapsing inflammatory skin disease that results in itchy, red, swollen, and cracked skin. Our work : BEN-2293, a Pan-Trk antagonist, is being developed to treat AD ...
Manufactured by:Entero Therapeutics, Inc. based inBoca Raton, FLORIDA (USA)
FW-UP is a niclosamide-based, oral small molecule anti-inflammatory inhibitor therapy for the treatment of ulcerative proctitis (UP) and ulcerative proctosigmoiditis (UPS). FW-UP is currently being investigated in a Phase 2b clinical trial study to study the safety and potential efficacy of niclosamide in patients with UP and ...
Manufactured by:Omni-Biotic based inPort Chester, NEW YORK (USA)
Combines valuable dietary fibers with important vitamins and minerals that serve as the food for essential, anaerobic probiotic bacteria, and promote intestinal health, strong gut barrier function as well as weight ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Triamcinolone hexacetonide is a commonly used long-acting steroids in treatment of subacute and chronic inflammatory joint ...
Manufactured by:Lyra Therapeutics, Inc. based inWatertown, MASSACHUSETTS (USA)
Lyra’s lead product candidate, LYR-210, to treat chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses. LYR-210 is an anti-inflammatory implantable drug matrix based upon Lyra’s XTreo™ platform designed to elute mometasone furoate consistently and locally to the inflamed mucosal ...